Skip to main content
. 2015 Jun 5;62(10):1805–1812. doi: 10.1002/pbc.25596

Table III.

Analyses of Group Differences in Cognitive Performance Between Brain Tumor Patients and Oncological Control Patients on Standardized Measures

Group Test statistics
Brain tumor patients (n = 20) Control patients (n = 27) Group comparisons Effect sizes
Function Measure n Median Range n Median Range U c P Φ (Phi)
Fluid intelligence (TONI‐3) a Nonverbal IQ 17 100 89–130 24 100 83–150 243.5 0.15 0.15
Intelligence (WISC‐IV) a Full scale IQ 20 99 77–117 27 108 67–132 339.0 0.051 0.26
Verbal comprehension (WISC Index) 20 100 81–126 27 101 67–126 272.5 0.48 0.01
Perceptual reasoning (WISC Index) 20 99 73–121 27 106 73–141 336.5 0.08 0.21
Working memory (WISC Index) 20 95 80–108 27 102 71–141 385.0 0.03* 0.28
Processing speed (WISC Index) 19 97 62–123 26 103 74–134 308.0 0.14 0.16
Verbal learning (RAVLT) a Learning (PR trial 1–5) 19 10 1–99 26 70 10–99 371.0 <0.01**(+) 0.41
Recall (PR trial 7) 19 14 1–99 26 69 1–99 330.5 0.01** 0.33
Recognition (PR) 19 53 1–88 26 75 5–88 312.0 0.03* 0.27
Verbal learning a Immediate recall (PR) 14 50 2–95 22 75 2–99 211.5 0.03* 0.27
(CMS Stories) a Delayed recall (PR) 14 44 2–99 22 80 2–99 218.0 <0.01**(+) 0.30
Delayed recognition (PR) 14 50 2–84 22 75 16–98 226.0 <0.001***(++) 0.47
Sustained attention (CPT‐II) b Commission errors (PR) 20 65 3–89 26 18 1–94 156.0 0.01** 0.34
Omission errors (PR) 20 38 21–99 26 36 20–96 244.0 0.36 0.27
Divided attention (TAP) a Commission errors (PR) 17 22 2–100 27 79 4–100 322.0 0.03* 0.34
Omission errors (PR) 17 29 1–100 27 46 1–96 293.5 0.12 0.05

Significance level: *P < 0.05; **P < 0.01; ***P = <0.001 (uncorrected); (+ = P < 0.05; ++ = P < 0.01 after Holm–Bonferroni‐Correction).

a

High values indicate good performance.

b

Low values indicate good performance.

c

Mann–Whitney U‐test. PR, percentile rank.